Articles written by: Ralph Creech

Aqua Metals (AQMS) Gets BidaskScore Lower Rating; Herald Investment Management LTD Lowered Silicon Motion Technology (SIMO) Position By $604,996

Aqua Metals (AQMS) Gets BidaskScore Lower Rating; Herald Investment Management LTD Lowered Silicon Motion Technology (SIMO) Position By $604,996

Herald Investment Management Ltd decreased Silicon Motion Technology Corp (SIMO) stake by 4.65% reported in 2018Q4 SEC filing. Herald Investment Management Ltd sold 17,794 shares as Silicon Motion Technology Corp (SIMO)’s stock rose 16.99%. The Herald Investment Management Ltd holds 365,206 shares with $12.60M value, down from 383,000 last quarter. […]

SORL Auto Parts, Inc. (SORL) EPS Estimated At $0.21; BOXSCORE BRANDS (BOXS) Sellers Decreased By 94.9% Their Shorts

SORL Auto Parts, Inc. (SORL) EPS Estimated At $0.21; BOXSCORE BRANDS (BOXS) Sellers Decreased By 94.9% Their Shorts

BOXSCORE BRANDS INC (OTCMKTS:BOXS) had a decrease of 94.9% in short interest. BOXS’s SI was 500 shares in March as released by FINRA. Its down 94.9% from 9,800 shares previously. It closed at $0.021 lastly. It is down 0.00% since March 25, 2018 and is . It has underperformed by […]

Analysts See $-0.35 EPS for Celsion (CLSN); Brookdale Senior Living (BKD) Shorts Decreased By 7.91%

Analysts See $-0.35 EPS for Celsion (CLSN); Brookdale Senior Living (BKD) Shorts Decreased By 7.91%

Analysts expect Celsion Corporation (NASDAQ:CLSN) to report $-0.35 EPS on March, 26.After having $-0.26 EPS previously, Celsion Corporation’s analysts see 34.62% EPS growth. The stock decreased 1.90% or $0.04 during the last trading session, reaching $2.06. About 471,275 shares traded or 235.38% up from the average. Celsion Corporation (NASDAQ:CLSN) has […]

Surface Oncology Inc. (SURF)’s Financial Results Comparing With InflaRx N.V. (NASDAQ:IFRX)

Both Surface Oncology Inc. (NASDAQ:SURF) and InflaRx N.V. (NASDAQ:IFRX) compete on a level playing field in the Biotechnology industry. We will evaluate their performance with regards to dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings […]

Eagle Point Credit Company Inc. (ECCB)’s Financial Results Comparing With Rand Capital Corporation (NASDAQ:RAND)

Both Eagle Point Credit Company Inc. (NYSE:ECCB) and Rand Capital Corporation (NASDAQ:RAND) compete on a level playing field in the Asset Management industry. We will evaluate their performance with regards to dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income […]

Onconova Therapeutics Inc. (ONTX)’s Financial Results Comparing With NantKwest Inc. (:)

As Biotechnology businesses, Onconova Therapeutics Inc. (NASDAQ:ONTX) and NantKwest Inc. (:), are affected by contrast. This especially applies to their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Onconova Therapeutics Inc. 1.31M 18.42 21.13M […]

Navidea Biopharmaceuticals Inc (NAVB)’s Financial Results Comparing With Unity Biotechnology Inc. (NASDAQ:UBX)

Both Navidea Biopharmaceuticals Inc (NYSEAMERICAN:NAVB) and Unity Biotechnology Inc. (NASDAQ:UBX) are each other’s competitor in the Biotechnology industry. Thus the compare of their institutional ownership, profitability, risk, dividends, analyst recommendations, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Navidea Biopharmaceuticals Inc […]

Reviewing Novus Therapeutics Inc. (NVUS)’s and Homology Medicines Inc. (NASDAQ:FIXX)’s results

Novus Therapeutics Inc. (NASDAQ:NVUS) and Homology Medicines Inc. (NASDAQ:FIXX) compete against each other in the Biotechnology sector. We will contrast them and contrast their risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Novus Therapeutics […]

Nuveen All Cap Energy MLP Opportunities Fund (JMLP) and Fidus Investment Corporation (NASDAQ:FDUS) Comparison side by side

Nuveen All Cap Energy MLP Opportunities Fund (NYSE:JMLP) and Fidus Investment Corporation (NASDAQ:FDUS) compete against each other in the Asset Management sector. We will compare them and contrast their risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per […]

Gyrodyne LLC (GYRO) and MFA Financial Inc. (NYSE:MFA.PB) Comparison side by side

Both Gyrodyne LLC (NASDAQ:GYRO) and MFA Financial Inc. (NYSE:MFA.PB) compete on a level playing field in the REIT – Diversified industry. We will evaluate their performance with regards to risk, analyst recommendations, profitability, dividends, earnings and valuation, institutional ownership. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per […]